By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Protagen and the Natural and Medical Sciences Institute at the University of Tubingen announced they will be developing multiplex assays for the diagnosis of autoimmune diseases and cancer.

The deal will leverage Protagen's expertise in the high-throughput expression of human proteins and clinical validation studies, and the institute's research platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.